Dr. Devchand Paul, DO, PhD
- Medicare services, 2024
- 10,275
- Medicare patients, 2024
- 563
- Part D claims, 2024
- 1,661
- Publications
- 16
- Clinical trials
- 2
- Practice address
- 4700 Hale Pkwy, Denver, CO 80220
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Rose Surgical Center - HOPD
Acute Care Hospital outpatient department · Denver, Colorado
Find Dr. Paul's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Devchand Paul is a hematologist and oncologist in Denver, Colorado
Dr. Paul practices at Rose Surgical Center - HOPD in Denver, Colorado.
Dr. Paul's NPI, 1841274164, was assigned on November 30, 2005. Dr. Paul graduated from Michigan State University College of Osteopathic Medicine in 1991. Dr. Paul holds Colorado license DR.0036997.
- NPI
- 1841274164NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9638187222
- NPI enumeration date
- November 30, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Devchand Paul practices at Rose Surgical Center - HOPD in Denver, Colorado
Dr. Paul's primary practice is Rose Surgical Center - HOPD, at 4700 Hale Pkwy, Denver, CO 80220.
- Rose Surgical Center - HOPD4700 Hale Pkwy, Denver, CO 80220
Source: Dmand AI Affiliation Data
Dr. Devchand Paul is affiliated with 6 sites of care and 1 medical group
Dr. Paul's primary practice is Rose Surgical Center - HOPD in Denver, Colorado. Dr. Paul is also affiliated with HCA HealthONE Rose. The medical group on file is Rocky Mountain Cancer Centers. Dmand AI also links Dr. Paul to 4 more hospitals, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Devchand Paul's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paul practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Rose Surgical Center - HOPD | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Devchand Paul is one of 179 hematologists and oncologists in Colorado
Hematology and oncology is Dr. Paul's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Paul is licensed in Colorado.
Specialties and state licenses
- Hematology and oncology, ColoradoPrimary
Hematologists and oncologists near Dr. Paul
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Devchand Paul billed Medicare for 10,275 services in 2024
CMS data shows 10,275 Medicare services from Dr. Paul across 26 procedure codes in 2024, for 563 Medicare patients. Medicare paid $284,785 for them.
Dr. Paul's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Lab and pathology
- 2023: 4,0582024: 3,9702%
- Drugs given in the office
- 2023: 5,1482024: 3,57631%
- Office and hospital visits
- 2023: 1,2862024: 1,289No change
- Surgery
- 2023: 7772024: 7296%
- Tests and treatments
- 2023: 6072024: 47322%
- Other services
- 2023: 992024: 238140%
Where Dr. Paul's Medicare services took place, 2024
- In an office10,21899%
- In a facility571%
Dr. Paul compared with the Colorado median for hematologists and oncologists, 2024
- Dr. Paul
- Colorado median
- Medicare services
- 10,275vs 62416.5 times
- Medicare patients
- 563vs 2422.3 times
- Part D claims
- 1,502vs 5033.0 times
Medians across 181 hematologists and oncologists in Colorado with Dmand AI profiles that report each measure.
Dr. Paul's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Paul?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Paul and other hematologists and oncologists in Colorado.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Devchand Paul treated 563 Medicare patients in 2024, average age 74
CMS counts 563 Medicare patients who saw Dr. Paul in 2024. The largest group is 65 to 74, with 300 patients. 75% of them have cancer, and 62% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Paul's median patient age at 70, with 95% women.
Dr. Paul's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Paul's Medicare patients by sex, 2024
- Women52693%
- Men377%
Chronic conditions among Dr. Paul's Medicare patients, 2024
- Cancer75%
- High cholesterol62%
- High blood pressure53%
- Arthritis48%
- Osteoporosis31%
- Mood disorders24%
- Depression21%
- Anxiety19%
Share of Medicare patients with each condition. A patient can have several.
Dr. Paul's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women95%
- Men4%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Devchand Paul wrote 1,661 Medicare Part D claims in 2024
In 2024, Dr. Paul wrote 1,661 Medicare Part D claims for 369 patients. 91% of them were for generic drugs. CMS names the drug for 1,502 of them, across 19 drugs with 11 or more claims each, at $1,257,530 in total drug cost. In 2023, CMS named 1,529 claims across 25 drugs.
Dr. Paul's Part D claims by kind of drug, 2024
- Generic1,517 claims91%
- Brand-name and other144 claims9%
Dr. Paul's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Paul's Part D claims, 2024
- Opioids1%16 of 1,661 claims
- Antibiotics1%18 of 1,661 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,5292024: 1,5022%
Drugs named by CMS: 19 in 2024, 25 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Devchand Paul scored 73 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 73 out of 100 for Dr. Paul for performance year 2024, reported through an alternative payment model (APM). Dr. Paul accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paul as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Paul's MIPS scores, performance year 2024
- 73of 100Final score
- 59.9of 100Quality
- 72of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Devchand Paul has 16 publications on record
Dmand AI links 16 papers to Dr. Paul, published from 2010 to 2019. 2011 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Weight Loss. Dr. Paul has published most often in Clin Breast Cancer. Dr. Paul's most frequent co-authors are Scot M. Sedlacek, MD, Joyce Ann O'Shaughnessy, MD and Svetislava Judith Vukelja, MD.
Dr. Paul's papers by year, 2010 to 2019
Topics Dr. Paul writes about most
- Breast Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Weight Loss
- Antibodies, Monoclonal, Humanized
- Body Mass Index
- Chemotherapy, Adjuvant
- Cyclophosphamide
- Survivors
Dr. Paul's most frequent co-authors
- Scot M. Sedlacek, MD6 shared papers
- Joyce Ann O'Shaughnessy, MD5 shared papers
- Svetislava Judith Vukelja, MD5 shared papers
Recent publications by Dr. Paul
See who Dr. Paul researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Paul works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Devchand Paul has worked on 2 clinical trials
Dmand AI links Dr. Paul to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.
Conditions in Dr. Paul's trials
- Breast Neoplasms
- Breast Diseases
Investigators on the most trials with Dr. Paul
- Neelima Denduluri, MD2 shared trials
- Paul D. Richards, MD2 shared trials
- Lee S. Schwartzberg, MD2 shared trials
Recent clinical trials with Dr. Paul
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer (opens in a new tab)
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Devchand Paul received $1,399 in industry payments from 2017 to 2025
CMS Open Payments shows 9 general payments to Dr. Paul from 5 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 71% of the total. TerSera Therapeutics LLC paid the most, $1,000.
General payments to Dr. Paul by program year, 2017 to 2025
General payments to Dr. Paul by kind, 2017 to 2025
- Consulting fees$1,00071%
- Education$36126%
- Food and beverage$393%
Companies that paid Dr. Paul the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Devchand Paul graduated from Michigan State University College of Osteopathic Medicine
Dr. Paul graduated from Michigan State University College of Osteopathic Medicine in 1991.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Devchand Paul's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Devchand Paul
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Devchand Paul's NPI number?
Dr. Devchand Paul's NPI number is 1841274164. It was assigned on November 30, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Devchand Paul?
Dr. Devchand Paul is a hematologist and oncologist in Denver, Colorado. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Devchand Paul practice?
Dr. Paul practices at 4700 Hale Pkwy, Denver, CO 80220. Dr. Paul's primary practice is Rose Surgical Center - HOPD in Denver, Colorado. Dmand AI also links Dr. Paul to 4 hospitals.
What is Dr. Devchand Paul's medical license number?
Dr. Paul holds Colorado license DR.0036997.
Which hospitals is Dr. Devchand Paul affiliated with?
Dr. Paul is affiliated with HCA HealthONE Rose. Dmand AI links Dr. Paul to 4 more hospitals.
What medical group is Dr. Devchand Paul part of?
Dr. Paul is linked to Rocky Mountain Cancer Centers.
Does Dr. Devchand Paul accept Medicare?
Yes. CMS data shows Dr. Paul billed Medicare for 10,275 services in 2024, and Dr. Paul accepts Medicare assignment.
Does Dr. Devchand Paul offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Paul as offering telehealth services.
What is Dr. Devchand Paul's MIPS score?
Dr. Paul's MIPS final score for performance year 2024 is 73 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Devchand Paul see?
CMS counts 563 Medicare patients who saw Dr. Paul in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. Devchand Paul bill to Medicare?
In 2024, Dr. Paul's most billed Medicare services were injected or infused drug (J0897), lab and pathology test (85025) and lab and pathology test (82378).
Where did Dr. Devchand Paul go to medical school?
Dr. Paul graduated from Michigan State University College of Osteopathic Medicine in 1991.
What drugs does Dr. Devchand Paul prescribe most?
In 2024 Medicare Part D data, Dr. Paul's most prescribed drugs by claims were Anastrozole, Lorazepam and Letrozole.
Has Dr. Devchand Paul received payments from drug or device companies?
CMS Open Payments shows $1,399 in general payments to Dr. Paul from 5 companies from 2017 to 2025. The largest total came from TerSera Therapeutics LLC.
How long has Dr. Devchand Paul been practicing?
Dr. Paul graduated from medical school in 1991, 35 years ago.
Does Dr. Devchand Paul do research?
Dmand AI links 16 publications to Dr. Paul, published from 2010 to 2019. Dr. Paul has worked on 2 clinical trials.
Who does Dr. Devchand Paul publish with?
Dr. Paul's most frequent co-authors are Scot M. Sedlacek, MD (6 shared papers), Joyce Ann O'Shaughnessy, MD (5 shared papers) and Svetislava Judith Vukelja, MD (5 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Colorado by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card